Literature DB >> 15149860

Intracellular trafficking and degradation of unassociated proalpha2 chains of collagen type I.

Marilyn G Gotkin1, Catherine R Ripley, Shireen R Lamande, John F Bateman, Robert S Bienkowski.   

Abstract

Procollagen I is a trimer consisting of two proalpha1(I) chains and one proalpha 2(I) chain. In certain cases of mild osteogenesis imperfecta, abnormal proalpha1(I) chains are degraded very soon after synthesis. As a consequence, the cells produce excess proalpha2(I) chains, which cannot form trimers and are not secreted. The objective of this work was to determine the intracellular fate of unassociated proalpha2(I) chains. Mov13 mouse fibroblasts, which do not synthesize proalpha1(I) mRNA, but do produce proalpha2(I) mRNA, were incubated with radioactive amino acids using pulse-chase protocols, and proteins were analyzed by gel electrophoresis, autoradiography, and Western blotting. Mov13 cells produced proalpha2(I) chains that were degraded intracellularly within 30 min. Degradation was inhibited when cells were treated with brefeldin-A, which blocks transit from endoplasmic reticulum to Golgi. Fixed cells exposed to various immunofluorescence markers and imaged by confocal laser scanning microscopy showed that proalpha2(I) chains colocalized with Golgi and lysosome markers. Degradation was inhibited and chains were secreted when cells were treated with wortmannin, which blocks trafficking to lysosomes. These results demonstrate that unassociated proalpha2(I) chains leave the endoplasmic reticulum, transit the Golgi, and enter lysosomes where they are degraded.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149860     DOI: 10.1016/j.yexcr.2004.01.029

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

Review 1.  Chaperoning osteogenesis: new protein-folding disease paradigms.

Authors:  Elena Makareeva; Nydea A Aviles; Sergey Leikin
Journal:  Trends Cell Biol       Date:  2010-12-21       Impact factor: 20.808

2.  Autophagic elimination of misfolded procollagen aggregates in the endoplasmic reticulum as a means of cell protection.

Authors:  Yoshihito Ishida; Akitsugu Yamamoto; Akira Kitamura; Shireen R Lamandé; Tamotsu Yoshimori; John F Bateman; Hiroshi Kubota; Kazuhiro Nagata
Journal:  Mol Biol Cell       Date:  2009-04-08       Impact factor: 4.138

3.  Prevention of liver fibrosis by triple helix-forming oligodeoxyribonucleotides targeted to the promoter region of type I collagen gene.

Authors:  Subramaniyan Koilan; David Hamilton; Narina Baburyan; Mythili K Padala; Karl T Weber; Ramareddy V Guntaka
Journal:  Oligonucleotides       Date:  2010-09-06

Review 4.  Cryptic collagen elements as signaling hubs in the regulation of tumor growth and metastasis.

Authors:  XiangHua Han; Jennifer M Caron; Peter C Brooks
Journal:  J Cell Physiol       Date:  2020-05-12       Impact factor: 6.384

5.  RNA Interference and BMP-2 Stimulation Allows Equine Chondrocytes Redifferentiation in 3D-Hypoxia Cell Culture Model: Application for Matrix-Induced Autologous Chondrocyte Implantation.

Authors:  Rodolphe Rakic; Bastien Bourdon; Magalie Hervieu; Thomas Branly; Florence Legendre; Nathalie Saulnier; Fabrice Audigié; Stéphane Maddens; Magali Demoor; Philippe Galera
Journal:  Int J Mol Sci       Date:  2017-08-24       Impact factor: 5.923

Review 6.  Collagen transport and related pathways in Osteogenesis Imperfecta.

Authors:  Lauria Claeys; Silvia Storoni; Marelise Eekhoff; Mariet Elting; Lisanne Wisse; Gerard Pals; Nathalie Bravenboer; Alessandra Maugeri; Dimitra Micha
Journal:  Hum Genet       Date:  2021-06-24       Impact factor: 4.132

7.  Improvement of the Chondrocyte-Specific Phenotype upon Equine Bone Marrow Mesenchymal Stem Cell Differentiation: Influence of Culture Time, Transforming Growth Factors and Type I Collagen siRNAs on the Differentiation Index.

Authors:  Thomas Branly; Romain Contentin; Mélanie Desancé; Thibaud Jacquel; Lélia Bertoni; Sandrine Jacquet; Frédéric Mallein-Gerin; Jean-Marie Denoix; Fabrice Audigié; Magali Demoor; Philippe Galéra
Journal:  Int J Mol Sci       Date:  2018-02-01       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.